slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 60,361-60,390
Pages 2,605
Rows per page 30
Component
60,361-60,390 of 78,138
15
The slide outlines a technical methodology for biological data generation.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
16
The slide includes a small schematic icon representing the scatter plot and a callout box emphasizing the necessity of high-quality data for AI training.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
20
The chart shows density vs -log10Kd, comparing design vs validation vs measured trastuzumab.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
21
The slide highlights the methodology of sampling sequence space and validating predictive models against measured binding affinity.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
22
The chart compares High vs Low Fidelity models with and without pretraining across different training data sizes.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
24
The slide uses a combination of diagrams and a summary box to explain the methodology of using AI to predict antibody naturalness.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style bar chart to represent clinical trial phases for each drug program.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
05
The chart uses stacked bars to represent cumulative patient population growth associated with clinical trial programs (PEDFIC, ASSERT, BOLD).Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations 1 hit
10
The chart displays LS Mean (95% CI) with p-value significance markers.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
11
The chart shows statistically significant improvements (p<=0.01) for the treatment group across all time points after baseline.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
08
The slide outlines a clinical trial protocol with two study arms (ADX-2191 vs. routine care) over a 6-month period.Aldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations 1 hit
10
Includes a forest plot for dichotomous endpoints.Aldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations 1 hit
12
Forest plot showing safety outcomes; includes p-value for overall effect.Aldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations 1 hit
07
The slide uses a 'plus' sign notation to illustrate the merger/combination of three distinct entities into one ecosystem.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Loop · Logic Chain1 hit
20
The slide uses a line chart to demonstrate performance stability relative to a benchmark.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Solution1 hit
38
Includes detailed footnotes regarding earn-outs, share forfeiture, and adjustments to enterprise value.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations 1 hit
03
The chart highlights a significant negative trend in free cash flow, with a specific callout for an 871% year-over-year decline.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
04
The chart shows negative cash flow values increasing in magnitude over the five quarters.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
05
The chart displays negative values for all periods shown, indicating a cash outflow trend.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
06
The chart illustrates share dilution management over five quarters.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
07
The chart includes a callout for growth metrics and a footnote explaining F/X adjustment methodology.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
09
The chart highlights a significant year-over-year decline in operating income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
10
The chart highlights a significant year-over-year decline in operating income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
11
Includes a footnote regarding a $1.1B pre-tax valuation gain in Q3 2022.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
12
The chart displays a significant downward trend in net income over the five reported quarters.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
06
Apollo Medical Holdings | Investor Presentation Deck | 45 slidesApollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
10
Apollo Medical Holdings | Investor Presentation Deck | 45 slidesApollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Problem1 hit
22
The chart demonstrates the efficacy of the ApolloMed tech-enabled ecosystem in improving patient engagement metrics.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction1 hit
24
The chart uses a grouped bar chart format to compare performance metrics across five categories.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction1 hit
26
The slide uses a three-part structure: historical performance ranking, a comparative bar chart of savings, and a forward-looking opportunity statement.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction1 hit